Bisgin A - Search Results

1

Pre-operative Neo-adjuvant Chemotherapy Related miRNAs as Key Regulators and Therapeutic Targets in Colorectal Cancer.

Yalav O, Sonmezler O, Erdogan KE, Rencuzogullari A, Doran F, Bisgin A, Boga I. Yalav O, et al. Among authors: bisgin a. Curr Aging Sci. 2024;17(1):49-57. doi: 10.2174/1874609816666230816152744. Curr Aging Sci. 2024. PMID: 37723961

2

Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma.

Yalcin AD, Bisgin A, Cetinkaya R, Yildirim M, Gorczynski RM. Yalcin AD, et al. Among authors: bisgin a. Clin Lab. 2013;59(1-2):71-7. doi: 10.7754/clin.lab.2012.120406. Clin Lab. 2013. PMID: 23505909

3

Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis.

Terzioglu E, Bisgin A, Sanlioglu AD, Ulker M, Yazisiz V, Tuzuner S, Sanlioglu S. Terzioglu E, et al. Among authors: bisgin a. Rheumatology (Oxford). 2007 May;46(5):783-9. doi: 10.1093/rheumatology/kel448. Epub 2007 Feb 19. Rheumatology (Oxford). 2007. PMID: 17309888

4

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis.

Yalcin AD, Gumuslu S, Parlak GE, Bısgın A. Yalcin AD, et al. Among authors: bisgin a. Med Sci Monit. 2012 Oct;18(10):CR617-21. doi: 10.12659/msm.883488. Med Sci Monit. 2012. PMID: 23018355 Free PMC article. Clinical Trial.

5

Jessner lymphocytic infiltrate as a side effect of bee venom immunotherapy.

Yalcin AD, Bisgin A, Akman A, Erdogan G, Ciftcioglu MA, Yegin O. Yalcin AD, et al. Among authors: bisgin a. J Investig Allergol Clin Immunol. 2012;22(4):308-9. J Investig Allergol Clin Immunol. 2012. PMID: 22812210 Free article. No abstract available.

6

Pollen aero allergens and the climate in Mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients.

Yalcin AD, Basaran S, Bisgin A, Polat HH, Gorczynski RM. Yalcin AD, et al. Among authors: bisgin a. Med Sci Monit. 2013 Feb 11;19:102-10. doi: 10.12659/msm.883762. Med Sci Monit. 2013. PMID: 23396359 Free PMC article.

7

Increased serum S-TRAIL level in newly diagnosed stage-IV lung adenocarcinoma but not squamous cell carcinoma is correlated with age and smoking.

Kargi A, Bisgin A, Yalcin AD, Kargi AB, Sahin E, Gumuslu S. Kargi A, et al. Among authors: bisgin a. Asian Pac J Cancer Prev. 2013;14(8):4819-22. doi: 10.7314/apjcp.2013.14.8.4819. Asian Pac J Cancer Prev. 2013. PMID: 24083751 Free article.

8

Trimetazidine effect on burn-induced intestinal mucosal injury and kidney damage in rats.

Yalcin AD, Bisgin A, Erbay RH, Oguz O, Demir S, Yilmaz M, Gumuslu S. Yalcin AD, et al. Among authors: bisgin a. Int J Burns Trauma. 2012;2(2):110-7. Epub 2012 Sep 15. Int J Burns Trauma. 2012. PMID: 23071909 Free PMC article.

9

Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatment.

Yalcin AD, Bisgin A, Kargi A, Gorczynski RM. Yalcin AD, et al. Among authors: bisgin a. Med Sci Monit. 2012 Mar;18(3):PI11-5. doi: 10.12659/msm.882504. Med Sci Monit. 2012. PMID: 22367138 Free PMC article.

10

Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels.

Yalcin AD, Cilli A, Bisgin A, Strauss LG, Herth F. Yalcin AD, et al. Among authors: bisgin a. Expert Opin Biol Ther. 2013 Sep;13(9):1335-41. doi: 10.1517/14712598.2013.819338. Epub 2013 Jul 24. Expert Opin Biol Ther. 2013. PMID: 23883435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters